X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1623) 1623
Publication (142) 142
Newsletter (86) 86
Book Review (14) 14
Book Chapter (3) 3
Dissertation (3) 3
Newspaper Article (3) 3
Magazine Article (2) 2
Reference (2) 2
Report (2) 2
Conference Proceeding (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1076) 1076
clofazimine (743) 743
clofazimine - therapeutic use (651) 651
male (537) 537
female (462) 462
adult (417) 417
leprosy - drug therapy (366) 366
drug therapy, combination (363) 363
index medicus (317) 317
middle aged (281) 281
rifampin - therapeutic use (272) 272
dapsone - therapeutic use (263) 263
animals (262) 262
clofazimine - pharmacology (249) 249
clofazimine - administration & dosage (241) 241
tuberculosis (226) 226
microbiology (222) 222
infectious diseases (218) 218
pharmacology & pharmacy (218) 218
leprostatic agents - therapeutic use (204) 204
mice (192) 192
clofazimine - adverse effects (178) 178
adolescent (159) 159
leprosy (151) 151
treatment outcome (142) 142
rifampin - administration & dosage (139) 139
dapsone - administration & dosage (128) 128
aged (125) 125
microbial sensitivity tests (121) 121
tropical medicine (121) 121
antitubercular agents - therapeutic use (111) 111
dermatology (109) 109
leprosy, lepromatous - drug therapy (107) 107
rifampin (100) 100
drug therapy (97) 97
mycobacterium tuberculosis - drug effects (96) 96
mycobacterium leprae - drug effects (93) 93
therapy (93) 93
leprostatic agents - administration & dosage (90) 90
ethambutol (88) 88
pathology (86) 86
child (85) 85
clarithromycin (85) 85
research (83) 83
mycobacterium avium-intracellulare infection - drug therapy (82) 82
drug resistance, microbial (77) 77
respiratory system (77) 77
immunology (76) 76
aids (73) 73
antitubercular agents - pharmacology (68) 68
drug resistance (68) 68
anti-bacterial agents - therapeutic use (67) 67
care and treatment (66) 66
drugs (64) 64
drug administration schedule (63) 63
mycobacterium avium complex (62) 62
mycobacterium-tuberculosis (62) 62
bedaquiline (61) 61
in-vitro (60) 60
infection (60) 60
leprostatic agents - adverse effects (60) 60
recurrence (59) 59
rifabutin (59) 59
rifampin - pharmacology (58) 58
retrospective studies (57) 57
tuberculosis, multidrug-resistant - drug therapy (56) 56
diagnosis, differential (55) 55
antibiotics (54) 54
clarithromycin - therapeutic use (54) 54
disease (54) 54
infections (54) 54
dapsone (53) 53
biopsy (52) 52
skin - pathology (52) 52
follow-up studies (51) 51
leprosy - microbiology (51) 51
time factors (51) 51
dermatology & venereal diseases (50) 50
dosage and administration (50) 50
drug resistance in microorganisms (50) 50
research article (50) 50
tuberculosis - drug therapy (48) 48
anti-bacterial agents - pharmacology (47) 47
dapsone - adverse effects (47) 47
ethambutol - therapeutic use (47) 47
leprosy, borderline - drug therapy (47) 47
medicine, general & internal (47) 47
clofazimine - pharmacokinetics (46) 46
clinical trials as topic (45) 45
dose-response relationship, drug (45) 45
multidrug-resistant tuberculosis (45) 45
aids-related opportunistic infections - drug therapy (44) 44
bacteremia (44) 44
mycobacterium avium complex - drug effects (44) 44
mycobacterium leprae - isolation & purification (44) 44
young adult (44) 44
dapsone - pharmacology (43) 43
pharmacokinetics (43) 43
anti-inflammatory agents, non-steroidal - therapeutic use (42) 42
antitubercular agents (42) 42
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1541) 1541
French (71) 71
German (48) 48
Spanish (19) 19
Portuguese (9) 9
Chinese (8) 8
Japanese (8) 8
Italian (7) 7
Polish (5) 5
Dutch (3) 3
Korean (3) 3
Danish (1) 1
Finnish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


MDT-MB therapy in paucibacillary leprosy: a clinicopathological assessment, 12/2005
BACKGROUND: The World Health Organization recommends treatment regimens for paucibacillary (PB) and multibacillary (MB) leprosy, which differ in their duration... 
Paucibacillary leprosy, Treatment, Clofazimine
Journal
British Journal of Dermatology, ISSN 0007-0963, 10/2019, Volume 181, Issue 4, pp. e88 - e88
Journal Article
Gastroenterology, ISSN 0016-5085, 2007, Volume 132, Issue 7, pp. 2313 - 2319
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Molecular Pharmaceutics, ISSN 1543-8384, 10/2011, Volume 8, Issue 5, pp. 1742 - 1749
Journal Article
Journal Article
CLINICAL INFECTIOUS DISEASES, ISSN 1058-4838, 10/2019, Volume 69, Issue 7, pp. 1259 - 1261
Journal Article
European Respiratory Journal, ISSN 0903-1936, 05/2017, Volume 49, Issue 5, pp. 1700387 - 1700387
Journal Article